Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"

被引：2
|
作者：
Caminati, Marco [1 ,2 ]
Crisafulli, Ernesto [2 ,3 ,4 ]
Lunardi, Claudio [1 ,2 ]
Micheletto, Claudio [5 ]
Festi, Giuliana [5 ]
Maule, Matteo [6 ]
Giollo, Alessandro [2 ,7 ]
Orsolini, Giovanni [7 ]
Senna, Gianenrico [1 ,2 ,8 ,9 ]
机构：
[1] Univ Verona, Dept Med, Verona, Italy
[2] Verona Univ Hosp, Verona, Italy
[3] Univ Verona, Dept Med, Resp Med Unit, Verona, Italy
[4] Univ Verona, Dept Med, Sect Internal Med, Verona, Italy
[5] Integrated Univ Hosp, Resp Unit, Cardiothorac Dept, Verona, Italy
[6] Univ Verona, Specializat Course Allergy & Clin Immunol, Dept Med, Verona, Italy
[7] Univ Verona, Verona Univ Hosp, Dept Med, Div Rheumatol, Verona, Italy
[8] Verona Univ Hosp, Allergy Unit, Verona, Italy
[9] Verona Univ Hosp, Asthma Ctr, Verona, Italy
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2021年 / 9卷 / 07期
关键词：
D O I：
10.1016/j.jaip.2021.04.029
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2943 / 2944
页数：2
相关论文
共 50 条
  • [31] Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
    Desaintjean, Charlene
    Ahmad, Kais
    Traclet, Julie
    Gerfaud-Valentin, Mathieu
    Durel, Cecile-Audrey
    Glerant, Jean-Charles
    Hot, Arnaud
    Lestelle, Francois
    Mainbourg, Sabine
    Nasser, Mouhamad
    Seve, Pascal
    Turquier, Segolene
    Devouassoux, Gilles
    Cottin, Vincent
    FRONTIERS IN MEDICINE, 2024, 11
  • [32] Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
    Masanobu Ueno
    Ippei Miyagawa
    Kazuhisa Nakano
    Shigeru Iwata
    Kentaro Hanami
    Shunsuke Fukuyo
    Satoshi Kubo
    Yusuke Miyazaki
    Akio Kawabe
    Hiroko Yoshinari
    Shingo Nakayamada
    Yoshiya Tanaka
    Arthritis Research & Therapy, 23
  • [33] MULTICENTRIC SPANISH ANALYSIS OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS PATIENTS TREATED WITH MEPOLIZUMAB
    Rubino, F.
    Garcia-Vicuna, R.
    Vicente-Rabaneda, E. F.
    Rodriguez Almaraz, E.
    Lozano Rivas, N.
    Freire Gonzalez, M.
    Olive, A.
    Nack, A.
    Narvaez, J.
    Moya, P.
    Uriarte Isacelaya, E.
    Alcorta Lorenzo, N.
    Marenco, L.
    Ramos Giraldez, C.
    Pinillos, V.
    Blanco, R.
    Benavides-Villanueva, F.
    Martinez-Vidal, M. P.
    Rua-Figueroa, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1587 - 1587
  • [34] Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis
    Rios-Garces, Roberto
    Prieto-Gonzalez, Sergio
    Hernandez-Rodriguez, Jose
    Arismendi, Ebymar
    Alobid, Isam
    Penatti, Alessandra E.
    Cid, Maria C.
    Espigol-Frigole, Georgina
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 95 : 61 - 66
  • [35] Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
    Ueno, Masanobu
    Miyagawa, Ippei
    Nakano, Kazuhisa
    Iwata, Shigeru
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Kubo, Satoshi
    Miyazaki, Yusuke
    Kawabe, Akio
    Yoshinari, Hiroko
    Nakayamada, Shingo
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [36] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
    Diaz-Campos, R. M.
    Prudencio-Ribera, V. C.
    Garcia-Moguel, I
    Fernandez-Rodriguez, C.
    Corral-Blanco, M.
    Jarrin-Estupinan, M. E.
    Melero-Moreno, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
  • [37] MEPOLIZUMAB INDUCTION THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
    Goldstein, M.
    Vadaketh, K.
    Dvorin, D.
    Belecanech, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
  • [38] Eosinophilic Granulomatosis with Polyangiitis: Mepolizumab recommended in current Guideline
    Fessler, Beate
    ALLERGO JOURNAL, 2024, 33 (07) : 49 - 51
  • [39] MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN REAL WORLD DATA
    Shoda, T.
    Takeuchi, T.
    Nagai, K.
    Konma, J.
    Arawaka, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 689 - 689
  • [40] Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
    Ueno, Masanobu
    Miyagawa, Ippei
    Aritomi, Takafumi
    Kimura, Koichi
    Iwata, Shigeru
    Hanami, Kentaro
    Fukuyo, Syunsuke
    Kubo, Satoshi
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
12345